Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough?
Jugdutt
Bodh I
BI
Division of Cardiology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada. bjugdutt@ualberta.ca
D000818:Animals; D000933:Antifibrinolytic Agents / Q000627:therapeutic use; D003094:Collagen / Q000502:physiology*; D016207:Cytokines / Q000378:metabolism; D005109:Extracellular Matrix / Q000187:drug effects / Q000502:physiology; D006321:Heart / Q000502:physiology; D006801:Humans; D020782:Matrix Metalloproteinases / Q000502:physiology; D008955:Models, Cardiovascular; D009203:Myocardial Infarction / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology; D020257:Ventricular Remodeling; D014945:Wound Healing
D000933:Antifibrinolytic Agents; D016207:Cytokines; D003094:Collagen; D020782:Matrix Metalloproteinases